Fund Holdings — Bain Capital Life Sciences Investors, LLC

Total Portfolio Value:
$675.91M
Total Bought:
$17.17M
Total Sold:
$21.92M
Net Transaction:
-$4.75M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Newamsterdam Pharma Company
ORDINARY SHARES
10,719,11010,719,1100$275.48M$219.42M32.46%-$56.06M
Nuvalent Inc1,447,2671,447,2670$113.29M$102.64M15.19%-$10.65M
Pharvaris N V
COM
3,303,3813,303,3810$63.33M$51.86M7.67%-$11.46M
Disc Medicine, Inc.(IRON)983,500983,5000$62.35M$48.82M7.22%-$13.53M
Dianthus Therapeutics, Inc.(DNTH)2,689,7072,689,7070$58.64M$48.79M7.22%-$9.84M
Savara Inc.(SVRA)14,565,45717,600,621+3,035,164$44.72M$48.75M7.21%+$4.04M
Solid Biosciences Inc4,034,5827,911,669+3,877,087$16.14M$29.27M4.33%+$13.13M
Olema Oncology, Inc.(OLMA)7,470,2146,843,954-626,260$43.55M$25.73M3.81%-$17.82M
Rapid Micro Biosystems, Inc.CL A(RPID)8,434,5608,434,5600$7.59M$22.27M3.29%+$14.68M
Cidara Therapeutics Inc703,080703,0800$18.90M$15.14M2.24%-$3.75M
Upstream Bio, Inc.(UPB)2,295,3222,295,3220$37.74M$14.05M2.08%-$23.69M
Annexon, Inc.(ANNX)5,249,0695,249,0690$26.93M$10.13M1.50%-$16.80M
Atea Pharmaceuticals, Inc.(AVIR)2,485,6382,485,6380$8.33M$7.43M1.10%-$894.8K
Kyverna Therapeutics, Inc.(KYTX)3,368,3703,368,3700$12.60M$6.50M0.96%-$6.10M
X4 Pharmaceuticals, Inc.(XFOR)16,915,78416,915,7840$12.41M$4.00M0.59%-$8.41M
Cabaletta Bio, Inc.(CABA)2,760,8882,760,8880$6.27M$3.82M0.57%-$2.44M
Tango Therapeutics, Inc.(TNGX)2,712,0082,712,0080$8.38M$3.72M0.55%-$4.66M
Xilio Therapeutics, Inc.(XLO)4,566,8174,566,8170$4.36M$3.31M0.49%-$1.05M
Mersana Therapeutics Inc8,663,6738,663,6730$12.39M$2.98M0.44%-$9.41M
Century Therapeutics, Inc.(IPSC)5,410,3615,410,3610$5.46M$2.58M0.38%-$2.89M
C4 Therapeutics, Inc.(CCCC)1,111,9101,111,9100$4.00M$1.78M0.26%-$2.22M
Invivyd, Inc.(IVVD)1,799,5951,799,5950$797.4K$1.09M0.16%+$291.9K
Nautilus Biotechnology, Inc.(NAUT)1,759,0001,072,421-686,579$2.96M$923.4K0.14%-$2.03M
Newamsterdam Pharma CompanyW EXP 99 99 999
*W EXP 99/99/999
100,000100,0000$1.43M$899.0K0.13%-$526.0K
Marinus Pharmaceuticals Inc2,693,3800-2,693,380$1.44M$0—-$1.44M
Syros Pharmaceuticals Inc2,750,1510-2,750,151$632.0K$0—-$632.0K
Page 1 of 1
Bain Capital Life Sciences Investors, LLC — 13F Holdings — Q1 2025 | TickerTrail